Published in AAPS J on April 17, 2013
Facilitating Mitochondrial Calcium Uptake Improves Activation-Induced Cerebral Blood Flow and Behavior after mTBI. Front Syst Neurosci (2016) 0.76
Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice. Exp Ther Med (2016) 0.75
An evaluation of the protective role of vitamin C in reactive oxygen species-induced hepatotoxicity due to hexavalent chromium in vitro and in vivo. J Occup Med Toxicol (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem (1979) 41.65
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24
Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem (1980) 10.52
Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem (1996) 2.25
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog (1995) 2.25
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology (2003) 1.92
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
MAMMALIAN GALACTOKINASE. DEVELOPMENTAL AND ADAPTIVE CHARACTERISTICS IN THE RAT LIVER. J Biol Chem (1965) 1.36
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol (2006) 1.25
Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine. Hum Exp Toxicol (2000) 1.24
Drug-grapefruit juice interactions. Mayo Clin Proc (2000) 1.19
Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice. J Hepatol (2006) 1.18
Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica (1996) 1.15
Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett (1999) 1.14
CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin (2004) 1.11
Clinical implications of CYP3A polymorphisms. Expert Opin Drug Metab Toxicol (2006) 1.11
Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos (2002) 1.05
In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol (2002) 1.04
Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther (1980) 1.01
Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol (2003) 1.00
Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1. Clin Pharmacol Ther (1993) 1.00
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. Am Rev Respir Dis (1984) 0.99
Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model. Toxicol Appl Pharmacol (2008) 0.98
Cytochrome P450 2E1-dependent oxidant stress and upregulation of anti-oxidant defense in liver cells. J Gastroenterol Hepatol (2006) 0.95
Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J Pharmacol Exp Ther (1999) 0.95
Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures. Br J Pharmacol (2007) 0.92
Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: A toxicity profile study. Hepatol Res (2007) 0.89
Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice. Life Sci (2000) 0.88
Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol (2008) 0.86
Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. Drug Metab Dispos (2004) 0.84
Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma. Xenobiotica (2002) 0.81
The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone--a novel galactose single-point method as a measure of residual liver function. Biopharm Drug Dispos (1994) 0.81
Assessment of liver function using a novel galactose single point method. Digestion (1992) 0.81
Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes? Br J Pharmacol (2009) 0.80
Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis. J Clin Pharmacol (1995) 0.79
The role of oxygen free radicals in isoniazid-induced hepatotoxicity. Methods Find Exp Clin Pharmacol (1998) 0.79
Determination of galactose in human blood by high-performance liquid chromatography: comparison with an enzymatic method and application to the pharmacokinetic study of galactose in patients with liver dysfunction. J Pharm Sci (1995) 0.77
Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells. Hum Exp Toxicol (1997) 0.76
Value of CT in the diagnosis and management of gallstone ileus. World J Gastroenterol (2005) 2.31
Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia (2005) 2.04
Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg (2008) 1.63
Unusual presentation of cystic liver metastases from nasopharyngeal carcinoma. Onkologie (2008) 1.46
Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer. Onkologie (2010) 1.44
Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma. J Gastroenterol Hepatol (2013) 1.43
Images in clinical medicine. Giant ovarian cyst. N Engl J Med (2008) 1.41
Intrauterine contraceptive device appendicitis: a case report. World J Gastroenterol (2005) 1.33
Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am J Physiol Cell Physiol (2009) 1.27
Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg (2010) 1.17
Bilateral superficial cervical plexus block combined with general anesthesia administered in thyroid operations. World J Surg (2010) 1.14
Missed brown tumors in a young adult with decreased bone density. South Med J (2010) 1.11
Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid (2008) 1.11
Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Cancer (2006) 1.11
Malignant mesenchymal tumor with leiomyosarcoma, rhabdomyosarcoma, chondrosarcoma, and osteosarcoma differentiation: case report and literature review. Diagn Pathol (2011) 1.11
Merkel cell carcinoma arising from the subcutaneous fat of the arm with intact skin. Dermatol Surg (2005) 1.10
Tophaceous gout of the knee: revisiting MRI patterns in 30 patients. J Clin Rheumatol (2010) 1.07
SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Int J Cancer (2007) 1.06
Management of spontaneously ruptured hepatocellular carcinoma and hemoperitoneum manifested as acute abdomen in the emergency room. World J Surg (2012) 1.06
Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med (2004) 1.06
Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands. Ann Surg Oncol (2008) 1.05
Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review. Onkologie (2012) 1.02
Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava: surgery or not? Dig Dis Sci (2007) 0.99
Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. Eur J Radiol (2011) 0.99
Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release (2006) 0.98
Aggressive angiomyxoma of supraclavicular fossa: a case report. Head Neck (2008) 0.97
Botryoid-type pleomorphic rhabdomyosarcoma of the renal pelvis in an adult. A rare case report and review of the literature. Urol Int (2006) 0.97
Cystic seminoma with elevated value of carbohydrate antigen 19-9 in tumor fluid mimicking cystic teratoma. Ann Thorac Surg (2009) 0.96
Ruptured hepatoblastoma with massive internal bleeding in an adult. World J Gastroenterol (2005) 0.96
Sclerosing encapsulating peritonitis in a liver transplant patient: a case report. World J Gastroenterol (2005) 0.95
Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria. Am J Surg (2010) 0.95
Cardiac tamponade as manifestation of advanced thymic carcinoma. Heart Lung (2005) 0.94
Littoral cell angioma of the spleen in a patient with hepatocellular carcinoma. J Formos Med Assoc (2005) 0.93
Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant (2004) 0.93
A novel mechanism underlies the hepatotoxicity of pyrazinamide. Antimicrob Agents Chemother (2013) 0.92
Tenosynovial lipoma arborescens of the ankle in a child. Skeletal Radiol (2005) 0.92
Peritoneal lavage with distilled water during liver resection in patients with spontaneously ruptured hepatocellular carcinomas. J Surg Oncol (2006) 0.92
Gallstone ileus with spontaneous resolution. Rev Esp Enferm Dig (2011) 0.92
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. J Neurooncol (2013) 0.92
MRI, arthroscopy, and histologic observations of an annular ligament causing painful snapping of the elbow joint. AJR Am J Roentgenol (2005) 0.91
On the AJR viewbox. Diffuse neurofibroma of the arm: MR characteristics. AJR Am J Roentgenol (2005) 0.91
A case of lung cancer metastasized to the gastrointestinal anastomosis site where the primary gastric cancer was resected 17 years ago. Lung Cancer (2011) 0.91
Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo. Am J Chin Med (2012) 0.91
Primary malignant mesothelioma of the greater omentum: report of a case. Surg Today (2004) 0.90
Acute anterior cruciate ligament stump entrapment in anterior cruciate ligament tears: MR imaging appearance. Radiology (2002) 0.89
Squamous Cell Carcinoma Arising From Massive Localized Lymphedema of Scrotum Mimicking Scrotal Smooth Muscle Hamartoma of Dartos: A Case Report. Am J Dermatopathol (2015) 0.89
Giant malignant gastrointestinal stromal tumors: recurrence and effects of treatment with STI-571. World J Gastroenterol (2005) 0.89
Increased matriptase zymogen activation in inflammatory skin disorders. Am J Physiol Cell Physiol (2010) 0.89
Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant (2005) 0.89
Anterior approach for a symptomatic giant hepatic haemangioma (>30 centimetre). ANZ J Surg (2006) 0.88
Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model. J Biomed Sci (2013) 0.87
Intra-articular injection of collagenase induced experimental osteoarthritis of the lumbar facet joint in rats. Eur Spine J (2008) 0.87
Pycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystals. Free Radic Biol Med (2011) 0.87
Matriptase expression in the normal and neoplastic mast cells. Eur J Dermatol (2007) 0.87
Predictors of the outcomes of acute-on-chronic hepatitis B liver failure. World J Gastroenterol (2012) 0.87
MRI features of lipoblastoma: differentiating from other palpable lipomatous tumor in pediatric patients. Clin Imaging (2010) 0.87
Accurate diagnosis and successful treatment for massive obscure small intestinal bleeding by means of intra-operative enteroscopy: a case report. Eur J Gastroenterol Hepatol (2008) 0.86
Tid1, CHIP and ErbB2 interactions and their prognostic implications for breast cancer patients. J Pathol (2011) 0.86
Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium. J Pathol (2005) 0.86
Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome. J Oral Pathol Med (2003) 0.86
Giant gallbladder: adenocarcinoma complicated with empyema. J Trauma (2011) 0.86
Malignant phyllodes tumor of the prostate. Int J Urol (2005) 0.86
Hyaluronic acid attenuates osteoarthritis development in the anterior cruciate ligament-transected knee: Association with excitatory amino acid release in the joint dialysate. J Orthop Res (2006) 0.86
Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma. Ann Surg Oncol (2011) 0.86
Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas. Clin Chem Lab Med (2014) 0.85
The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm (2005) 0.85
Gastric residual volume (GRV) and gastric contents measurement by refractometry. JPEN J Parenter Enteral Nutr (2007) 0.85
Attenuation of mouse mesangial cell contractility by high glucose and mannitol: involvement of protein kinase C and focal adhesion kinase. J Biomed Sci (2004) 0.85
Intraosseous ganglion cyst of the capitate treated by intralesional curettage, autogenous bone marrow graft and autogenous fibrin clot graft. J Chin Med Assoc (2007) 0.85
Kimura's disease of the elbows. Skeletal Radiol (2005) 0.85
Refractory atrial fibrillation following tube thoracostomy. CMAJ (2010) 0.84
Methylation of histone H3 lysine 27 associated with apoptosis in osteosarcoma cells induced by staurosporine. Histol Histopathol (2009) 0.84
The (-1486T/C) promoter polymorphism of the TLR-9 gene is associated with end-stage knee osteoarthritis in a Chinese population. J Orthop Res (2011) 0.84
Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.84
The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma. APMIS (2012) 0.83
Helicobacter pylori infection in relation to E-cadherin gene promoter polymorphism and hypermethylation in sporadic gastric carcinomas. World J Gastroenterol (2005) 0.83
Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int (2004) 0.83
Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver. Onkologie (2007) 0.83
Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas. World J Gastroenterol (2006) 0.82
Sequential change in T2* values of cartilage, meniscus, and subchondral bone marrow in a rat model of knee osteoarthritis. PLoS One (2013) 0.82
Acute heart failure as manifestation of metastatic uterine leiomyosarcoma to the heart and lung. Heart Lung (2004) 0.82
Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible. Ann Vasc Surg (2010) 0.82
DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer (2005) 0.82
Effects of (-)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts. Rheumatol Int (2009) 0.82
Association between Osteopontin and EGFR Expression with Clinicopathological Parameters in Hepatocellular Carcinoma. Chin J Physiol (2012) 0.82
Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.82
Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridization. Gynecol Oncol (2005) 0.81
Pharmacokinetics of oral rosiglitazone in Taiwanese and post hoc comparisons with Caucasian, Japanese, Korean, and mainland Chinese subjects. J Pharm Pharm Sci (2007) 0.81
Fluid-fluid level in peripheral nerve schwannoma: report of a case with histological correlation. Clin Imaging (2009) 0.81
Primary malignant fibrous histiocytoma of the thyroid: review of the literature with two new cases. Thyroid (2008) 0.81
Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study. PLoS One (2013) 0.80
Increased concentrations of neuro-excitatory amino acids in rat anterior cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res (2005) 0.80
Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats. Metabolism (2007) 0.80
Association of a functional polymorphism in the promoter region of TLR-3 with osteoarthritis: a two-stage case-control study. J Orthop Res (2012) 0.80
Granular cell tumor of the scrotum: a case report and literature review. Indian J Pathol Microbiol (2013) 0.80
Duodenal mantle cell lymphoma in a patient with advanced sigmoid adenocarcinoma. South Med J (2009) 0.80
Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg (2009) 0.80